Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration

Prostate

Volumn 43, Issue 3, 2000, Pages 184-194

  Burchardt, Martin ^a,b   Burchardt, Tatjana ^a   Chen, Min Wei ^a   Hayek, Omar R ^a   Knight, Charles ^a   Shabsigh, Ahmad ^a   De La Taille, Alexandre ^a   Buttyan, Ralph ^a,c  

^a Columbia University ^*  (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Atchley Pavilion   (United States)

Author keywords

Androgens; Apoptosis; Castration; Prostate; Vascular endothelial growth factor A

Indexed keywords

ANDROGEN; ANTIBODY; MESSENGER RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD FLOW; CASTRATION; CONTROLLED STUDY; DEGENERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ANDROGENS; ANIMALS; BLOTTING, WESTERN; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; ORCHIECTOMY; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0034057871     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000515)43:3<184::AID-PROS4>3.0.CO;2-6     Document Type: Article

References (32)

1. Colombel MC, Buttyan R. Hormonal control of apoptosis: the rat prostate gland as a model system: Methods Cell Biol 1995; 46:369-385.
2. Buttyan R, Shabsigh A, Perlman H, Colombel M. Regulation of apoptosis in the prostate gland by androgenic steroids. Trends Endocrinol Metab 1999;10:47-52.
3. Shabsigh A, Chang DT, Heitjan DF, Kiss A, Olsson CA, Puchner PJ, Buttyan R. Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 1998;36:201-206.
4. Shabisgh A, Tanji N, D'Agati V, Burchardt M, Rubin M, Goluboff ET, Heitjan D, Kiss A, Buttyan R. Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology 1999;140:1920-1926.
5. Hayek O, Shabsigh A, Kaplan SA, Kiss AJ, Chen MW, Burchardt T, Burchardt M, Olsson CA, Buttyan R. Castration induces acute vasoconstriction of blood vessel in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity. J Urol 1999;162:1527-1531.
6. Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991; 129:3187-3199.
7. Kyprianou N, Isaacs JT. Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. Endocrinology 1988;123: 2124-2131.
8. Pewitt EB, Haleem R, Wang Z. Adrenomedullin gene is abundantly expressed and directly regulated by androgen in the rat ventral prostate. Endocrinology 1999;140:2382-2386.
9. Weiss G. Relaxin in the male. Biol Reprod 1989;40:197-200.
10. Katz AE, Benson MC, Wise GJ, Olsson CA, Bandyk MG, Sawczuk IS, Tomashefsky P, Buttyan R. Gene activity during the early phase of androgen-stimulated rat prostate regrowth. Cancer Res 1989;49:5889-5894.
11. Haggstrom S, Wikstrom P, Bergh A, Damber JE. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration. Prostate 1998;36:71-79.
12. Burchardt M, Burchardt T, Chen MW, Shabsigh A, de la Taille A, Buttyan R, Shabsigh R. Expression of messenger RNA splice variants for vascular endothelial growth factor in the adult rat and human penis. Biol Reprod 1999;60:398-404.
13. Burchardt T, Burchardt M, Chen MW, de la Taille A, Shabsigh A, Buttyan R, Shabsigh R. Expression of VEGF splice variants 144/145 and 205 in adult male tissues. IUBMB Life 1999;48: 405-408.
14. Nor JE, Christensen J, Mooney DJ, Polverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;154:375-384.
15. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 1990;87:2628-2632.
16. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998;273:30336-30343.
17. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13:9-22.
18. Meeson AP, Argilla M, Ko K, Witte L, Lang RA. VEGF deprivation-induced apoptosis is a component of programmed capillary regression. Development 1999;126:1407-1415.
19. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res 1999;5:783-789.
20. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998;51:161-167.
21. Melnyk O, Zimmerman M, Kim KJ, Shuman M. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. J Urol 1999;161:960-963.
22. Borgstrom P, Bourdon MA, Hillan KJ, Sriramarao P, Ferrara N. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma microtumors in vivo. Prostate 1998;35:1-10.
23. Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P, Bohlen P. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev 1998;17:155-161.
24. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999;237:1-30.
25. Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999;9:211-220.
26. Haagstrom S, Franck Lissbrant I, Bergh A, Damber J-E. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol 1999;161:1620-1625.
27. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97-132.
28. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-1039.
29. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999;26:74-84.
30. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, Lavie P, Roguin A, Levy AP. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999;100:547-552.
31. Buttyan R, Zakeri Z, Lockshin RA, Wolgemuth D. Cascade induction of c-fos, c-myc and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 1988;2:650-657.
32. De la Taille A, Chen MW, Shabsigh A, Bagiella E, Kiss A, Buttyan R. Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland. Prostate 1999;40:89-96.